secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001213900-25-086568
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology raises $9.0M in registered direct offering and warrant private placement
--------------------------------------------------------------------------------

- Sold 5,142,858 shares and warrants for 5,142,858 shares at $1.75/unit for gross proceeds of $9.0M.
- Net proceeds approximately $7.48M after placement agent fees and expenses.
- Warrants exercisable at $1.84/share, starting six months post-issuance, expiring in 5.5 years.
- Maxim Group acted as placement agent, receiving 7% cash fee and warrants for 205,714 shares at $1.92.
- Promissory note with Citius Pharma amended: maturity now contingent on raising at least $30M aggregate capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025086568/0001213900-25-086568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025086568/ea0256723-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-086568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer